Related Experiment Videos
Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Developments in the treatment of early NSCLC: when to use chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Exploration of tumor genomics associated with prolonged benefit from or resistance to talazoparib monotherapy in patients with metastatic castration-resistant prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Clinically actionable genetic findings by exome sequencing performed for therapeutic purposes in children with very-high risk cancer included the MAPPYACTS study.
European journal of cancer (Oxford, England : 1990)·2026
Single-item measures of perceived side effect burden for people with cancer: A systematic scoping review.
European journal of cancer (Oxford, England : 1990)·2026
Refining neoplasm risk in DICER1-related tumor predisposition.
European journal of cancer (Oxford, England : 1990)·2026
Towards a more proportionate EU framework for low-intervention clinical trials: Lessons from the UK and Switzerland.
European journal of cancer (Oxford, England : 1990)·2026
Recent trends in childhood, teenage and young adult cancer incidence in England (2001-2020).
European journal of cancer (Oxford, England : 1990)·2026